Bir olgu nedeniyle sklerozan enkapsüle peritonit

Amaç: Cerrahi Kliniğimizde karşılaştığımız, nadir görülen idiopatik sklerozan enkapsüle peritonitli (SEP) bir vaka takdim edilmekte ve hastalığın klinik tablosu ve cerrahi tedavisi anlatılmaktadır. Makalenin amacı, literatür bilgileri ışığında SEP'in tüm klinik özelliklerinin gözden geçirilmesidir. Olgu sunumu: Hastanın tedavisi; fibröz dokunun çıkarılması, nekrotik bir ileal segmentin rezeksiyonu ve primer anastomozla barsak bütünlüğünün sağlanmasından oluşmaktaydı. Teknik açıdan sonuç iyi olmasına rağmen postoperatif beşinci günde anastomotik ve septik komplikasyonlar gelişti. Hastaya ikinci bir ameliyatla, ileumda anastomoz kaçağının oluştuğu segment ve kalın barsakta nekroz gelişen bir alan stoma şeklinde dışarı alındı. Postoperatif gidiş kötüydü. Abdominal sepsis ve pnömoni nedeniyle hasta kaybedildi. Sonuç: SEP nadir görülmesine rağmen ağır seyreder. En önemli komplikasyonu intestinal obstrüksiyondur. Özet olarak: (1) mümkünse membranın rezeksiyonuna çalışılmalı; (2) barsak yaralanması oluşursa, en proksimaldeki barsak segmenti stoma şeklinde dışarı alınmalı ve parsiyel rezeksiyonlar primer anastomoz edilmemeli, (3) asemptomatik hastalarda cerrahi tedaviden kaçınılmalıdır. İnce barsak obstrüksiyonunun ayırıcı tanısı ve cerrahi tedavisinde SEP mutlaka akla gelmelidir.

A case report of sclerosing encapsulating peritonitis

Objective: We reported a rare case of idiopathic sclerosing encapsulating peritonitis (SEP) observed in our surgical department and described its clinical behavior and surgical treatment. The aim of this article was to review all clinical aspects of SEP in the light of literature. Case report: Treatment of the patient is consisted of removal of fibrous tissue, resection of a necrotic ileal segment and intestinal reconstruction primary anastomosis. From technical point of view the result was good but anastomotic and septic complications arose on fifth postoperative day. The patient was underwent second operation. Disrupted anastomotic segment in the ileum and a necrotic area in the large bowel were brought as stoma. Postoperative course was worse and the patient died due to abdominal sepsis and pneumonia. Conclusion: Though infrequent, but SEP is very severe. The main complication is intestinal obstruction. As a result: (1) resection of the membrane should be attempted when feasible; (2) in case of inadvertent intestinal wound(s), the most proximal one should be brought out as a stoma, and partial resections should not be anastomosed primarily, (3) no surgical treatment is required in asymptomatic patients. SEP should be kept in mind in the differential diagnosis and surgical management of small bowel obstruction.

___

  • 1. Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of sclerosing encapsulating peritonitis. Arch Surg 1990; 125:1626-8.
  • 2. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996;28:420-7.
  • 3. Carbonnel F, Barrie F, Beaugerie L, Houry S, Chatelet F, Gallot D, et al. Sclerosing peritonitis. A series of 10 cases and review of the literature. Gastroenterol Clin Biol 1995;19:876-82.
  • 4. Assalia A, Schein M, Hashmonai M. Problems in the surgical management of sclerosing encapsulating peritonitis. Isr J Med Sci 1993;29:686-8.
  • 5. Yokota S, Kumano K, Sakai T. Prognosis for patients with sclerosing encapsulating peritonitis following CAPD. Adv Perit Dial 1997;13:221-3.
  • 6. Rigby RJ, Hawley CM. Sclerosing peritonitis: The experience in Australia. Nephrol Dial Transplant 1998;13:154-9.
  • 7. Smith L, Collins JF, Morris M, Teele RL. Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: Surgical management. Am J Kidney Dis 1997;29:456-60.
  • 8. Narayanan R, Bhargava BN, Kabra SG, Sangal BC. Idiopathic sclerosing encapsulating peritonitis. Lancet 1989;2:127-9.
  • 9. Thompson RP, Jackson BT. Sclerosing peritonitis due to practolol. Br Med J 1977;1:1393-4.
  • 10. Panting AL, Denham HE. Drug-induced sclerosing peritonitis. N Z Med J 1977;85:10-2
  • 11. Keating JP, Neill M, Hill GL. Sclerosing encapsulating peritonitis after intraperitoneal use of povidone iodine. Aust N Z J Surg 1997;67:742-4.
  • 12. Cohen O, Abrahamson J, Ben-Ari J, Frajewicky V, Eldar S. Sclerosing encapsulating peritonitis. J Clin Gastroenterol 1996;22:54-7.
  • 13. Burstein M, Galun E, Ben-Chetrit E. Idiopathic sclerosing peritonitis in a man. J Clin Gastroenterol 1990;12:698-701.
  • 14. Yanagi H, Kusunoki M, Yamamura T. Possible development of idiopathic sclerosing encapsulating peritonitis. Hepatogastroenterol 1999;46:353-6.
  • 15. Masuda C, Fujii Y, Kamiya T, Miyamoto M, Nakahara K, Hattori S, et al. Idiopathic sclerosing peritonitis in a man. Intern Med 1993;32:552-5.
  • 16. Deeb LS, Mourad FH, El-Zein YR, Uthman SM. Abdominal cocoon in a man: Preoperative diagnosis and literature review. J Clin Gastroenterol 1998;26:148-50.
  • 17. Pusateri R, Ross R, Marshall R, Meredith JH, Hamilton RW. Sclerosing encapsulating peritonitis: Report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature. Am J Kidney Dis 1986;8:56-60.
  • 18. Carbonnel F, Barrie F, Beaugerie L, Houry S, Chatelet F, Gallot D, et al. Sclerosing peritonitis. A series of 10 cases and review of the literature. Gastroenterol Clin Biol 1995;19:876-82.